When GRP78 releases from the complex, PERK is stimulated to promote the phosphorylation of nuclear factor erythroid 2-related factor 2 (NRF2), which plays an antioxidative role in cancer cells [32, 33]. The gene discussed is EIF2AK3; the disease is cancer.